Vetoquinol SA (LON:0O1O)
London · Delayed Price · Currency is GBP · Price in EUR 73.60
-1.60 (-2.13%)
At close: Nov 4, 2025
Vetoquinol Revenue
Vetoquinol had revenue of 257.63M EUR in the half year ending June 30, 2025, with 0.54% growth. This brings the company's revenue in the last twelve months to 532.39M, down -0.95% year-over-year. In the year 2024, Vetoquinol had annual revenue of 539.20M with 1.88% growth.
Revenue (ttm)
532.39M EUR
Revenue Growth
-0.95%
P/S Ratio
1.68
Revenue / Employee
212.87K EUR
Employees
2,501
Market Cap
766.88M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
| Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
| Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
| Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
| Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Vetoquinol News
- 7 weeks ago - Vetoquinol SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Vetoquinol SA reports 1H results - Seeking Alpha